Skip to content

Sex differences in the effects of the combined exposure to cephalad fluid shift and mild hypercapnia on cerebral autoregulation

Sex differences in the effects of the combined exposure to cephalad fluid shift and mild hypercapnia on cerebral autoregulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1030230757
Enrollment
50
Registered
2024-03-29
Start date
2024-06-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attenuated cerebral autoregulation due to microgravity Cerebrovascular circulation

Interventions

-10 degree head down tilt and 3% carbon dioxide inhalation
D006935, D018475
Hypercapnia, Head-Down Tilt

Sponsors

Iwasaki Kenichi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Persons who are within the age range of 18 to 35 at the time of consent. 2)Persons who have voluntarily consented to participate in this study, after being fully informed and understanding the study. 3)Persons who were determined to be healthy after a medical history and physical examination. 4)Women with menstrual cycles within the normal range (25 to 38 days). 5)Persons who can have a stable brain blood flow velocity waveform displayed by transcranial Doppler sonography in the supine position at rest.

Exclusion criteria

Exclusion criteria: 1)Persons who have refused to participate in this study. 2Ppersons deemed ineligible by the principal investigator, such as those taller than 180 cm due to the specifications of the adjustable tilt electric bed. 3)Persons with or a history of cardiovascular diseases (including hypertension and arrhythmia), neurological disorders, respiratory diseases, autonomic nervous system dysfunction, severe systemic diseases, or anemia that has not been improved by treatment (as identified through medical history and physical examination). 4)Persons with a history of hypersensitivity to ultrasound transmission gel or other skin reactions (confirmed by medical interview) 5)Women taking oral contraceptives or other hormonal agents, those with irregular menstrual cycles (outside the normal range of 25 to 38 days), and pregnant women 6)Women whose menstrual cycles make it difficult to schedule experiments during the follicular phase

Design outcomes

Primary

MeasureTime frame
cerebral blood flow velocity in the middle cerebral artery Index of dynamic cerebral autoregulation : gain, phase, coherence

Secondary

MeasureTime frame
heart rate, blood pressure, respiratory rate, end-tidal carbon dioxide concentration, percutaneous saturation of arterial oxygen

Contacts

Public ContactKodai Sugimura

Nihon University

meko23005@g.nihon-u.ac.jp+81-3-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026